Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer
Abstract DNA mismatch repair deficiency (dMMR) testing is crucial for diagnosing Lynch syndrome and detection of microsatellite unstable (MSI) tumors eligible for immunotherapy. The aim of this study was to compare the relative diagnostic performance of three molecular MSI assays: polymerase chain r...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e513393128942018dcc7c80a00264c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0e513393128942018dcc7c80a00264c0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0e513393128942018dcc7c80a00264c02021-12-02T16:04:26ZComparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer10.1038/s41598-021-91974-x2045-2322https://doaj.org/article/0e513393128942018dcc7c80a00264c02021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91974-xhttps://doaj.org/toc/2045-2322Abstract DNA mismatch repair deficiency (dMMR) testing is crucial for diagnosing Lynch syndrome and detection of microsatellite unstable (MSI) tumors eligible for immunotherapy. The aim of this study was to compare the relative diagnostic performance of three molecular MSI assays: polymerase chain reaction (PCR), MSI testing by Idylla and next-generation-sequencing (NGS) on 49 tumor samples (28 colorectal and 21 endometrial adenocarcinomas) versus immunohistochemistry (IHC). Discrepancies were investigated by MLH1 methylation analysis and integrated with germline results if available. Overall, the molecular assays achieved equivalent diagnostic performance for MSI detection with area under the ROC curves (AUC) of respectively 0.91 for Idylla and PCR, and 0.93 for NGS. In colorectal cancers with tumor cell percentages ≥ 30% all three molecular assays achieved 100% sensitivity and specificity (AUC = 1) versus IHC. Also, in endometrial cancers, all three molecular assays showed equivalent diagnostic performance, albeit at a clearly lower sensitivity ranging from 58% for Idylla to 75% for NGS, corresponding to negative predictive values from 78 to 86%. PCR, Idylla and NGS show similar diagnostic performance for dMMR detection in colorectal and endometrial cancers. Molecular MSI analysis has lower sensitivity for dMMR detection in endometrial cancer indicating that combined use of both IHC and molecular methods is recommended. Clinical Trial Number/IRB: B1172020000040, Ethical Committee, AZ Delta General Hospital.Franceska DedeurwaerdereKathleen BM ClaesJo Van DorpeIsabelle RottiersJoni Van der MeulenJoke BreyneKoen SwaertsGeert MartensNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Franceska Dedeurwaerdere Kathleen BM Claes Jo Van Dorpe Isabelle Rottiers Joni Van der Meulen Joke Breyne Koen Swaerts Geert Martens Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
description |
Abstract DNA mismatch repair deficiency (dMMR) testing is crucial for diagnosing Lynch syndrome and detection of microsatellite unstable (MSI) tumors eligible for immunotherapy. The aim of this study was to compare the relative diagnostic performance of three molecular MSI assays: polymerase chain reaction (PCR), MSI testing by Idylla and next-generation-sequencing (NGS) on 49 tumor samples (28 colorectal and 21 endometrial adenocarcinomas) versus immunohistochemistry (IHC). Discrepancies were investigated by MLH1 methylation analysis and integrated with germline results if available. Overall, the molecular assays achieved equivalent diagnostic performance for MSI detection with area under the ROC curves (AUC) of respectively 0.91 for Idylla and PCR, and 0.93 for NGS. In colorectal cancers with tumor cell percentages ≥ 30% all three molecular assays achieved 100% sensitivity and specificity (AUC = 1) versus IHC. Also, in endometrial cancers, all three molecular assays showed equivalent diagnostic performance, albeit at a clearly lower sensitivity ranging from 58% for Idylla to 75% for NGS, corresponding to negative predictive values from 78 to 86%. PCR, Idylla and NGS show similar diagnostic performance for dMMR detection in colorectal and endometrial cancers. Molecular MSI analysis has lower sensitivity for dMMR detection in endometrial cancer indicating that combined use of both IHC and molecular methods is recommended. Clinical Trial Number/IRB: B1172020000040, Ethical Committee, AZ Delta General Hospital. |
format |
article |
author |
Franceska Dedeurwaerdere Kathleen BM Claes Jo Van Dorpe Isabelle Rottiers Joni Van der Meulen Joke Breyne Koen Swaerts Geert Martens |
author_facet |
Franceska Dedeurwaerdere Kathleen BM Claes Jo Van Dorpe Isabelle Rottiers Joni Van der Meulen Joke Breyne Koen Swaerts Geert Martens |
author_sort |
Franceska Dedeurwaerdere |
title |
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
title_short |
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
title_full |
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
title_fullStr |
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
title_full_unstemmed |
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
title_sort |
comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/0e513393128942018dcc7c80a00264c0 |
work_keys_str_mv |
AT franceskadedeurwaerdere comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT kathleenbmclaes comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT jovandorpe comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT isabellerottiers comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT jonivandermeulen comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT jokebreyne comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT koenswaerts comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer AT geertmartens comparisonofmicrosatelliteinstabilitydetectionbyimmunohistochemistryandmoleculartechniquesincolorectalandendometrialcancer |
_version_ |
1718385190662832128 |